Elana Plotkin

ORCID: 0000-0002-0635-5721
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Economic and Financial Impacts of Cancer
  • Frailty in Older Adults
  • Palliative Care and End-of-Life Issues
  • COVID-19 and healthcare impacts
  • Lung Cancer Treatments and Mutations
  • Global Cancer Incidence and Screening
  • Ethics in Clinical Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Telemedicine and Telehealth Implementation
  • Cancer survivorship and care
  • Nutrition and Health in Aging
  • Lung Cancer Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Advances in Oncology and Radiotherapy
  • Patient-Provider Communication in Healthcare
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Protein purification and stability
  • Cognitive Science and Mapping
  • Neutropenia and Cancer Infections
  • Statistical Methods in Clinical Trials
  • Health disparities and outcomes
  • Pharmaceutical industry and healthcare
  • Colorectal Cancer Screening and Detection
  • Monoclonal and Polyclonal Antibodies Research

Association of Community Cancer Centers
2018-2025

CancerCare
2024

Waseda University
2023

Memorial Sloan Kettering Cancer Center
2019

University of Rochester Medical Center
2019

Thomas Jefferson University Hospital
2019

City of Hope
2019

Gynecologic Oncology Group
2019

Fox Chase Cancer Center
2019

Lancaster General Hospital
2019

Importance While an overwhelming majority of patients diagnosed with cancer express willingness to participate in clinical trials, only a fraction will enroll onto research protocol. Objective To identify critical barriers trial enrollment translate findings into actionable practice changes that increase enrollment. Design, Setting, and Participants This survey study included designated site contacts at oncology practices teams who were highly involved the Association Community Cancer...

10.1001/jamanetworkopen.2024.8739 article EN cc-by-nc-nd JAMA Network Open 2024-04-29

697 Background: Rates of guideline-concordant treatment for BLCA remain <50%, driven by access and care delivery barriers. The Association Cancer Care Centers (ACCC) designed a 6-month QI program to identify implement site-specific strategies support equitable at cancer programs. We aim characterize findings from participating sites’ pre-implementation assessments as well initial directions QI. Methods: ACCC was conducted with programs between November 2023 – 2024, guided an advisory...

10.1200/jco.2025.43.5_suppl.697 article EN Journal of Clinical Oncology 2025-02-10

ObjectivesCare for older adults with cancer became more challenging during the COVID-19 pandemic. We sought to examine healthcare providers' clinical barriers, patient questions, and overall experiences related care delivery these patients pandemic.Materials methodsMembers of Advocacy Committee Cancer Aging Research Group along Association Community Centers developed a 20-question survey providers cancer. Eligible participants were recruited by email sent through professional organizations'...

10.1016/j.jgo.2020.09.021 article EN other-oa Journal of Geriatric Oncology 2020-09-18

Care for older adults with cancer became more challenging during the COVID-19 pandemic. We sought to examine care providers' attitudes toward barriers and facilitators related these patients pandemic.Members of Advocacy Committee Cancer Aging Research Group, along Association Community Centers, developed survey distributed multidisciplinary healthcare providers responsible direct cancer. Participants were recruited by email sent through four professional organizations' listservs, blasts,...

10.1016/j.jgo.2020.09.028 article EN other-oa Journal of Geriatric Oncology 2020-10-05

Abstract Background: Oncology programs may encounter many challenges engaging in clinical trials. The Association of Community Cancer Center’s (ACCC) Research Institute (ACORI) conducted a survey to gather insights on barriers trial provision and implementation, patient recruitment, identifying resources support cancer programs. Methods: A 29 questions was administered via Qualtrics. focused research-naïve sites (i.e., with little no research experience). Survey recipients were identified...

10.1158/1538-7445.am2024-999 article EN Cancer Research 2024-03-22

Abstract Introduction: Triple-negative breast cancer (TNBC) presents unique challenges due to its aggressive nature and limited treatment options. Black women are disproportionately affected by TNBC, experiencing higher incidence rates poorer outcomes compared other racial/ethnic groups. This study aims evaluate disparities in access quality care for with TNBC from the perspective of oncology healthcare providers. Methods: From December 2022 February 2023, Association Community Cancer...

10.1158/1538-7445.sabcs23-po5-06-10 article EN Cancer Research 2024-05-02

e13649 Background: Effective integration between EHRs and cancer biomarker testing processes is an unmet need across academic community settings. Despite the benefits of EHR-integrated workflows desire for streamlined test results, as supported by a recent ASCO Workforce Survey, many health systems do not currently have this capacity, especially when reference labs are external to ordering institution. Methods: The Association Cancer Care Centers (ACCC) convened live summit on October 4,...

10.1200/jco.2024.42.16_suppl.e13649 article EN Journal of Clinical Oncology 2024-05-29

e13172 Background: The Association of Cancer Care Centers (ACCC) launched a quality improvement initiative in 2018 to address suboptimal germline BRCA1/2 testing rates and identify barriers impeding for patients with early-stage or metastatic breast cancer. Between 2023, changes clinical guidelines led expanded criteria increased referrals genetic testing. A follow-up survey 2023 aimed assess practices challenges faced by cancer care teams, considering the evolving landscape impact COVID-19...

10.1200/jco.2024.42.16_suppl.e13172 article EN Journal of Clinical Oncology 2024-06-01

6079 Background: Head and neck cancer (HNC) is a complex disease that requires multidisciplinary care poses significant challenges for patients healthcare providers. Despite the availability of evidence-based guidelines, achieving optimal HNC faces many barriers. This mixed-methods study explores perceived barriers by clinicians to care. Methods: The Association Cancer Care Centers (ACCC) collaborated with Neck Alliance American Society Radiation Oncology (ASTRO), along an expert steering...

10.1200/jco.2024.42.16_suppl.6079 article EN Journal of Clinical Oncology 2024-06-01

25 Background: Financial advocates (also known as navigators/counselors) are an increasingly important role on the multidisciplinary team to improve equitable access care by assessing and addressing risks of financial distress for people with cancer their families. The Association Cancer Care Centers (ACCC) recently published consensus-driven guidelines delivering advocacy (FA) services, but field still lacks standard definition roles, responsibilities, metrics, benchmarks. ACCC’s Advocacy...

10.1200/op.2024.20.10_suppl.25 article EN JCO Oncology Practice 2024-09-30

78 Background: The Rural Appalachian Lung Cancer Screening Initiative is led by the Association of Care Centers (ACCC) and patient advocacy partners. Recognized White House Moonshot, this initiative seeks to improve lung cancer screening rates partnering with health systems in rural Appalachia develop implement interventions. An 11-county region bordering West Virginia, Kentucky has significantly higher mortality incidence than national 35.0 54.0 per 100,000 people, respectively (Table 1)....

10.1200/op.2024.20.10_suppl.78 article EN JCO Oncology Practice 2024-09-30

21 Background: In 2023, the Association of Cancer Care Centers (ACCC) Financial Advocacy Network published Services Guidelines developed through an expert-led, consensus-driven process (1). The provide a framework for equitable delivery financial advocacy (FA) services to address patients’ concerns. cover 3 domains: and functions, program management partner engagement functions. ACCC adapted into Assessment Tool help cancer care organizations assess improve service advance research...

10.1200/op.2024.20.10_suppl.21 article EN JCO Oncology Practice 2024-09-30

Abstract Introduction/Objective Guideline-driven tumor biomarker testing remains standard of care for precision oncology due to the increasing number treatment decisions that can be made based on tumor-specific alterations. However, most electronic health record (EHR) systems lack bidirectional interfaces with labs enable computerized order entry and results. Without these integrations, cancer centers may experience delays in test ordering resulting, manual data errors, operational...

10.1093/ajcp/aqae129.225 article EN American Journal of Clinical Pathology 2024-10-01
Coming Soon ...